Literature DB >> 21296116

Towards validated assays for key immunological outcomes in malaria vaccine development.

David R Cavanagh, Patrice M Dubois, Andreas Holtel, Agnes Kisser, Odile Leroy, Emily Locke, Vasee S Moorthy, Edmond J Remarque, Ya Ping Shi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21296116     DOI： 10.1016/j.vaccine.2011.01.070

Source DB:  PubMed          Journal:  Vaccine        ISSN： 0264-410X            Impact factor:   3.641


× No keyword cloud information.
  3 in total

1.  A polyvalent hybrid protein elicits antibodies against the diverse allelic types of block 2 in Plasmodium falciparum merozoite surface protein 1.

Authors:  Kevin K A Tetteh; David J Conway
Journal:  Vaccine       Date:  2011-08-04       Impact factor: 3.641

2.  Evidence that seasonal malaria chemoprevention with SPAQ influences blood and pre-erythrocytic stage antibody responses of Plasmodium falciparum infections in Niger.

Authors:  Lamine Mahaman Moustapha; Rafiou Adamou; Maman Laminou Ibrahim; Mariama Abdoulaye Louis Padounou; Abdoulaye Diallo; David Courtin; Jean Testa; Jean Louis Abdourahim Ndiaye
Journal:  Malar J       Date:  2021-01-01       Impact factor: 2.979

3.  Validation of an enzyme-linked immunosorbent assay for the quantification of human IgG directed against the repeat region of the circumsporozoite protein of the parasite Plasmodium falciparum.

Authors:  Frederic Clement; Vincent Dewar; Eva Van Braeckel; Isabelle Desombere; Marianne Dewerchin; Christine Swysen; Marie-Ange Demoitié; Erik Jongert; Joe Cohen; Geert Leroux-Roels; Pierre Cambron
Journal:  Malar J       Date:  2012-11-22       Impact factor: 2.979
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.